- Report
- February 2023
- 152 Pages
Global
From €2158EUR$2,500USD£1,870GBP
- Report
- January 2023
- 61 Pages
Global
From €2158EUR$2,500USD£1,870GBP
- Report
- December 2022
- 66 Pages
Global
From €3021EUR$3,500USD£2,618GBP
- Report
- November 2022
- 148 Pages
Global
From €4748EUR$5,500USD£4,113GBP
- Report
- September 2022
- 257 Pages
Global
From €4748EUR$5,500USD£4,113GBP
- Report
- June 2022
- 124 Pages
Global
From €4748EUR$5,500USD£4,113GBP
- Report
- January 2022
- 133 Pages
Global
From €4748EUR$5,500USD£4,113GBP
- Report
- November 2021
- 295 Pages
Global
From €4748EUR$5,500USD£4,113GBP
- Report
- June 2021
- 58 Pages
Global
From €3410EUR$3,950USD£2,954GBP
- Report
- November 2020
- 260 Pages
Global
From €2374EUR$2,750USD£2,057GBP
- Report
- August 2020
- 139 Pages
Global
From €2374EUR$2,750USD£2,057GBP
- Report
- January 2020
- 54 Pages
Global
From €1705EUR$1,975USD£1,477GBP
- Report
- November 2019
- 167 Pages
Global
From €2374EUR$2,750USD£2,057GBP
- Report
- January 2019
- 144 Pages
Global
From €2374EUR$2,750USD£2,057GBP
- Report
- November 2018
- 147 Pages
Global
From €2374EUR$2,750USD£2,057GBP
- Report
- April 2023
- 145 Pages
Global
From €5136EUR$5,950USD£4,450GBP
- Report
- July 2024
- 296 Pages
Global
From €2115EUR$2,450USD£1,832GBP
- Report
- May 2024
- 325 Pages
Global
From €2115EUR$2,450USD£1,832GBP
- Report
- March 2024
- 254 Pages
Global
From €2115EUR$2,450USD£1,832GBP
- Report
- March 2024
- 221 Pages
Global
From €2115EUR$2,450USD£1,832GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more